These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24903228)

  • 1. Can magnetic resonance spectroscopy differentiate endometrial cancer?
    Zhang J; Cai S; Li C; Sun X; Han X; Yang C; Fu C; Liu Q; Xin Y; Zong Y
    Eur Radiol; 2014 Oct; 24(10):2552-60. PubMed ID: 24903228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the signal-to-noise ratio of choline in magnetic resonance spectroscopy reflect the aggressiveness of endometrial cancer?
    Han X; Kang J; Zhang J; Xiu J; Huang Z; Yang C; Sun X; Fu C; Liu Q
    Acad Radiol; 2015 Apr; 22(4):453-9. PubMed ID: 25641318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.
    Dorrius MD; Pijnappel RM; van der Weide Jansen MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Eur Radiol; 2012 Apr; 22(4):915-22. PubMed ID: 22076317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance spectroscopy associations with clinicopathologic features of estrogen-dependent endometrial cancer.
    Zhang J; Liu Q; Li J; Liu Z; Wang X; Li N; Huang Z; Xu H
    BMC Med Imaging; 2022 Jul; 22(1):127. PubMed ID: 35850646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
    Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
    Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
    Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer.
    Ytre-Hauge S; Esmaeili M; Sjøbakk TE; Grüner R; Woie K; Werner HM; Krakstad C; Bjørge L; Salvesen ØO; Stefansson IM; Trovik J; Bathen TF; Haldorsen IS
    Acta Radiol; 2018 Apr; 59(4):497-505. PubMed ID: 28927296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
    Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
    Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
    Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
    Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors?
    Galati F; Luciani ML; Caramanico C; Moffa G; Catalano C; Pediconi F
    Invest Radiol; 2019 Dec; 54(12):767-773. PubMed ID: 31356383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
    Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
    Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality fMRI with perfusion, diffusion-weighted MRI and
    Zhu L; Wang J; Shi H; Tao X
    J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.
    King AD; Yeung DK; Yu KH; Mo FK; Hu CW; Bhatia KS; Tse GM; Vlantis AC; Wong JK; Ahuja AT
    Eur Radiol; 2010 Jan; 20(1):165-72. PubMed ID: 19652977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.